Candel Therapeutics, Inc. CADL Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Candel Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Candel Therapeutics, Inc.'s change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Candel Therapeutics, Inc.'s change in other assets?
- Candel Therapeutics, Inc. (CADL) reported change in other assets of $1.26M in Q1 2026.
- How has Candel Therapeutics, Inc.'s change in other assets changed year-over-year?
- Candel Therapeutics, Inc.'s change in other assets increased by 854.5% year-over-year, from -$167K to $1.26M.
- What is the long-term trend for Candel Therapeutics, Inc.'s change in other assets?
- Over 2 years (2021 to 2024), Candel Therapeutics, Inc.'s change in other assets has grown at a 67.9% compound annual growth rate (CAGR), from -$83K to -$234K.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.